---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-178757"
form_type: "8-K"
ticker: "AGIO"
cik: "0001439222"
company_name: "AGIOS PHARMACEUTICALS, INC."
filed_at: "2022-06-22T23:59:59+00:00"
generated_at: "2026-06-24T23:56:40.065634+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Agios shareholders elect directors, approve say-on-pay, ratify PwC at 2022 annual meeting

## Summary
- Elected Jacqualyn A. Fouse, David Scadden, David P. Schenkein as class III directors (48.5M, 48.5M, 45.4M votes for).
- Advisory vote on executive compensation approved: 45.0M for, 4.5M against, 9K abstain.
- Shareholders recommended say-on-pay every 1 year (48.7M votes); Board adopts annual frequency.
- Ratified PricewaterhouseCoopers LLP as independent auditor for fiscal 2022: 50.6M for, 140K against.
- Broker non-votes of 1.17M on director elections and advisory items.

## SEC filing metadata
- accession: 0001193125-22-178757
- form_type: 8-K
- ticker: AGIO
- cik: 0001439222
- company_name: AGIOS PHARMACEUTICALS, INC.
- filed_at: 2022-06-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1439222/000119312522178757/0001193125-22-178757-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1439222/000119312522178757/d342593d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-178757
- JSON: https://secwatch.observer/filing/0001193125-22-178757.json
- Plain text: https://secwatch.observer/filing/0001193125-22-178757.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.